These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis.

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems," said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

The 2025 fellows have been invited to the annual AAAS Fellows Forum May 29 in Washington, D.C.

Even modest reductions in salt consumption could reduce the burden of heart failure in high-risk populations.

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

Kropski is a physician-scientist whose research has helped advance the understanding and potential treatment of interstitial lung disease.